Founded in 2017, Prosoma is a medical technology company developing digital therapeutics solutions for cancer patients through its Software-as-a-Medical-Device platform. The company offers a suite of clinically validated applications that support patients across their entire treatment journey, including symptom management, psychosocial care, and behavioral therapy. Designed to be prescribed by healthcare professionals, Prosoma’s solutions deliver personalized, evidence-based interventions accessible anytime and anywhere. Built in compliance with strict medical standards such as ISO 13485, ISO 62304, and ISO 27001, the platform is developed in collaboration with medical experts, patients, and leading research partners. By combining technology with clinical validation, Prosoma aims to improve patient outcomes and become a global leader in oncology-focused digital therapeutics.